Hologic Rating Lowered to Hold at Standpoint Research (HOLX)
Hologic (NASDAQ:HOLX) was downgraded by equities research analysts at Standpoint Research from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports.
Hologic (NASDAQ:HOLX) traded down 0.81% on Wednesday, hitting $25.59. 2,627,491 shares of the company’s stock traded hands. Hologic has a one year low of $18.46 and a one year high of $26.18. The stock has a 50-day moving average of $24.6 and a 200-day moving average of $22.50. The company’s market cap is $7.071 billion.
Hologic (NASDAQ:HOLX) last announced its earnings results on Wednesday, April 30th. The company reported $0.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.33 by $0.04. The company had revenue of $625.00 million for the quarter, compared to the consensus estimate of $609.35 million. On average, analysts predict that Hologic will post $1.40 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on HOLX. Analysts at Zacks reiterated a “neutral” rating on shares of Hologic in a research note on Wednesday, June 25th. They now have a $26.00 price target on the stock. Separately, analysts at Needham & Company LLC raised their price target on shares of Hologic from $26.00 to $30.00 in a research note on Wednesday, June 25th. They now have a “buy” rating on the stock. Finally, analysts at Argus raised their price target on shares of Hologic from $27.00 to $31.00 in a research note on Monday, May 12th. They now have a “buy” rating on the stock. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $23.83.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.